Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Roghayeh Navabi"'
Autor:
Mahmoud Izadi, Anavasadat Sadr Hashemi Nejad, Maedeh Moazenchi, Safdar Masoumi, Ali Rabbani, Farzad Kompani, Amir Abbas Hedayati Asl, Fatemeh Abbasi Kakroodi, Neda Jaroughi, Mohammad Ali Mohseni Meybodi, Aria Setoodeh, Farzaneh Abbasi, Seyedeh Esmat Hosseini, Fatemeh Moeini Nia, Reza Salman Yazdi, Roghayeh Navabi, Ensiyeh Hajizadeh-Saffar, Hossein Baharvand
Publikováno v:
Stem Cell Research & Therapy, Vol 13, Iss 1, Pp 1-20 (2022)
Abstract Background Type-1 diabetes (T1D) occurs following autoimmune-induced pancreatic beta cells death. Among several treatment modalities, mesenchymal stem cells (MSCs) transplantation is promising for autoimmune disorders due to immunomodulation
Externí odkaz:
https://doaj.org/article/717c452c20084f148ec905010a66a23f
Autor:
Maedeh Moazenchi, Seyedeh Esmat Hosseini, Fatemeh Abbasi, Mohamad Ali Mohseni Meybodi, Mahmoud Izadi, Neda Jarooghi, Anavasadat Sadr Hashemi Nejad, Reza Salman Yazdi, Farzaneh Abbasi, Amir Abbas Hedayati Asl, Roghayeh Navabi, Hossein Baharvand, Ali Rabbani, Safdar Masoumi, Ensiyeh Hajizadeh-Saffar, Fatemeh Moeini Nia, Farzad Kompani, Aria Setoodeh
BackgroundType-1 diabetes (T1D) occurs following autoimmune-induced pancreatic beta cells death. Among several treatment modalities, Mesenchymal Stem Cells (MSCs) transplantation is promising for autoimmune disorders due to immunomodulation, regenera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8896e871c2ec36daa202329c78de2f32
https://doi.org/10.21203/rs.3.rs-921850/v1
https://doi.org/10.21203/rs.3.rs-921850/v1
Autor:
Mahmoud Izadi, Anavasadat Sadr Hashemi Nejad, Maedeh Moazenchi, Safdar Masoumi, Ali Rabbani, Farzad Kompani, Amir Abbas Hedayati Asl, Fatemeh Abbasi Kakroodi, Neda Jaroughi, Mohammad Ali Mohseni Meybodi, Aria Setoodeh, Farzaneh Abbasi, Seyedeh Esmat Hosseini, Fatemeh Moeini Nia, Reza Salman Yazdi, Roghayeh Navabi, Ensiyeh Hajizadeh-Saffar, Hossein Baharvand
Publikováno v:
Stem cell researchtherapy. 13(1)
BackgroundType-1 diabetes (T1D) occurs following autoimmune-induced pancreatic beta cells death. Among several treatment modalities, mesenchymal stem cells (MSCs) transplantation is promising for autoimmune disorders due to immunomodulation, regenera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23ca46bde0ee2c30ed6b28c68bdd5264
https://pubmed.ncbi.nlm.nih.gov/35725652
https://pubmed.ncbi.nlm.nih.gov/35725652
Autor:
Seyedeh-Nafiseh Hassani, Ensiyeh Hajizadeh-Saffar, Maryam Hezavehei, Roghayeh Navabi, Mohamad Pakzad, Mostafa Hajinasrollah, Mohammad Jafari-Atrabi, Babak Negahdari, Hossein Baharvand, Shahram Rabbani, Yaser Jenab, Yaser Tahamtani
Publikováno v:
Life Sciences. 276:119374
Aims Immunomodulation concurrent with the promotion of β-cell function is a strategy used to develop innovative therapies for type 1 diabetes (T1D). Here, we assessed the therapeutic potential of co-administration of human clonal mesenchymal stem (s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17771c78a8d61e08c1efd793bdc53ee8
https://doi.org/10.1016/j.lfs.2021.119374
https://doi.org/10.1016/j.lfs.2021.119374
Autor:
Izadi, Mahmoud1,2 (AUTHOR), Sadr Hashemi Nejad, Anavasadat1,2 (AUTHOR), Moazenchi, Maedeh1,2 (AUTHOR), Masoumi, Safdar3 (AUTHOR), Rabbani, Ali4 (AUTHOR), Kompani, Farzad5 (AUTHOR), Hedayati Asl, Amir Abbas6,7 (AUTHOR), Abbasi Kakroodi, Fatemeh1,2 (AUTHOR), Jaroughi, Neda1,2 (AUTHOR), Mohseni Meybodi, Mohammad Ali1,2 (AUTHOR), Setoodeh, Aria8 (AUTHOR), Abbasi, Farzaneh4 (AUTHOR), Hosseini, Seyedeh Esmat9 (AUTHOR), Moeini Nia, Fatemeh1 (AUTHOR), Salman Yazdi, Reza10 (AUTHOR), Navabi, Roghayeh1 (AUTHOR), Hajizadeh-Saffar, Ensiyeh2,6,11 (AUTHOR) en.hajizadeh@royan-rc.ac.ir, Baharvand, Hossein1,12 (AUTHOR) h.baharvand@royan-rc.ac.ir
Publikováno v:
Stem Cell Research & Therapy. 6/20/2022, Vol. 13 Issue 1, p1-20. 20p.